|
Volumn No. 116, Issue , 1996, Pages 3-4
|
Costing xenotransplantation.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ANIMAL;
ARTICLE;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
HUMAN EXPERIMENT;
IMUTRAN LTD.;
ORGAN TRANSPLANTATION;
SANDOZ PHARMACEUTICALS CORP.;
SWINE;
TRANSGENIC ANIMAL;
UNITED KINGDOM;
UNITED STATES;
XENOGRAFT;
HEALTH CARE AND PUBLIC HEALTH;
IMUTRAN LTD.;
SANDOZ PHARMACEUTICALS CORP.;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
DRUG INDUSTRY;
ECONOMICS;
GREAT BRITAIN;
HUMAN EXPERIMENTATION;
HUMANS;
ORGAN TRANSPLANTATION;
PHARMACEUTICAL PREPARATIONS;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
UNITED STATES;
|
EID: 0030091941
PISSN: 09629564
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|